An estimation of the effect of 100% Compliance with Diabetes Treatment: Can we reduce cost of illness with higher compliance rates?
Introduction: The current study was designed to estimate the direct cost of noncompliance of diabetes patients to the US health system. Understanding these expenses can inform screening and education budget policy regarding expenditure levels that can be calculated to be cost-beneficial. Materials a...
Saved in:
Main Authors: | Guvenc Kockaya (Author), Albert I. Wertheimer (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
http://z.umn.edu/INNOVATIONS 2011, Vol. 2, No. 2, Article 45 INNOVATIONS in pharmacy 1 An estimation of the effect of 100% Compliance with Diabetes Treatment: Can we reduce cost of illness with higher compliance rates?
by: Güvenç Koçkaya, MD, et al.
Published: (2011) -
Will Translational Science Help Reduce Costs of Illness?
by: Guvenc Kockaya, et al.
Published: (2010) -
Will Translational Science Help Reduce Costs of Illness?
by: Albert I. Wertheimer, PhD, et al.
Published: (2010) -
Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, et al.
Published: (2010) -
Compliance to HIV treatment monitoring guidelines can reduce laboratory costs
by: Naseem Cassim, et al.
Published: (2016)